This activity is part of the Frankly Speaking with Dr. Frank Domino podcast series.
Frankly Speaking CME 236

Podcast

Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking EP 236Guest: Robert A. Baldor, MD, FAAFP
Music Credit: Richard Onorato

Continuous glucose monitoring (CGM) for patients with diabetes has been available for several years now, but its utility in managing diabetes care is unclear. Join us to discuss the results of a systematic review examining the benefits of CGM for patients with both type 1 and type 2 diabetes mellitus.

Episode References and Resources:

  • Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials. Diabetes Care. 2020;43(5):1146-1156.
  • Implementing Continuous Glucose Monitoring in Clinical Practice. www.aafp.org/fpm March/April 2021
  • Longo R, Sperling S. Personal versus professional continuous glucose monitoring: when to use which on whom. Diabetes Spectr. 2019;32(3):183-193.
     

Begin

Already listened on another platform?

Claim Credits

CME/CE Information

0 Credits - Not for CME/CE Credit

Release Date: 8/9/2021

Expiration Date: 8/9/2022

Learning Objectives

  • Explain the methods for continuous glucose monitoring (CGM)
  • Assess the data on the benefits of CGM for patients with diabetes
  • Appreciate the complexities for ordering CGM for patients with diabetes
     

 

Faculty

Frank J. Domino, MD

Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Learn More

Robert A. Baldor, MD, FAAFP

Professor and Chairman, Dept of Family Medicine
UMass Medical School/Baystate 

Learn More

Supporters and Partners

Commercial Supporter

Not Applicable

Education Partner

Not Applicable

Continuous Glucose Monitoring—What’s All the Hype? - Frankly Speaking EP 236

Begin